Nobuhisa Masuda Selected Research

DS86760016

1/2019	DS86760016, a Leucyl-tRNA Synthetase Inhibitor with Activity against Pseudomonas aeruginosa.
1/2018	In Vitro and In Vivo Activities of DS86760016, a Novel Leucyl-tRNA Synthetase Inhibitor for Gram-Negative Pathogens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nobuhisa Masuda Research Topics

Disease

3	Infections 01/2021 - 08/2005
3	Clostridium Infections 12/2018 - 01/2018
2	Urinary Tract Infections (Urinary Tract Infection) 01/2019 - 01/2018
1	Cystic Fibrosis (Mucoviscidosis) 01/2021
1	Pseudomonas Infections 01/2019
1	Body Weight (Weight, Body) 01/2018
1	Gram-Negative Bacterial Infections 01/2018
1	Bacterial Infections (Bacterial Infection) 08/2005

Drug/Important Bio-Agent (IBA)

4	DS-2969bIBA 12/2018 - 01/2018
2	DS86760016IBA 01/2019 - 01/2018
2	Vancomycin FDA LinkGeneric 01/2018 - 08/2005
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2021
1	Virulence Factors (Pathogenicity Factors)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	FidaxomicinIBA 01/2018
1	Linezolid (Zyvox)FDA Link 01/2018
1	3- (aminomethyl)- 7- (3- hydroxypropoxy)- 1- hydroxy- 1,3- dihydro- 2,1- benzoxaboroleIBA 01/2018
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 08/2005
1	Meropenem (Merrem)FDA LinkGeneric 08/2005
1	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 08/2005
1	tomopenemIBA 08/2005
1	Ceftazidime (Fortum)FDA LinkGeneric 08/2005

Therapy/Procedure

1	Catheters 01/2019
1	Oral Administration 01/2018
1	Therapeutics 01/2018